GI CANCER CHRONICLES Trademark
Trademark Overview
On Thursday, March 14, 2024, a trademark application was filed for GI CANCER CHRONICLES with the United States Patent and Trademark Office. The USPTO has given the GI CANCER CHRONICLES trademark a serial number of 98449528. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, September 3, 2024. This trademark is owned by Astellas Pharma Inc.. The GI CANCER CHRONICLES trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing medical information
General Information
Serial Number | 98449528 |
Word Mark | GI CANCER CHRONICLES |
Filing Date | Thursday, March 14, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Tuesday, September 3, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Pseudo Mark | GASTROINESTINAL CANCER CHRONICLES |
Goods and Services | Providing medical information |
Classification Information
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 14, 2024 |
Primary Code | 044 |
First Use Anywhere Date | Monday, March 4, 2024 |
First Use In Commerce Date | Monday, March 4, 2024 |
Trademark Owner History
Party Name | Astellas Pharma Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Tokyo 103-8411 JP |
Trademark Events
Event Date | Event Description |
Thursday, March 14, 2024 | NEW APPLICATION ENTERED |
Wednesday, August 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Friday, August 30, 2024 | ASSIGNED TO EXAMINER |
Tuesday, September 3, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, September 3, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, September 3, 2024 | NON-FINAL ACTION WRITTEN |